• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1170名无症状挪威应征入伍者中严重急性呼吸综合征冠状病毒2的流行情况

Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscripts.

作者信息

Borud Einar Kristian, Nakstad Espen Rostrup, Håberg Siri Eldevik, Lind Andreas, Fadum Elin Anita, Taxt Arne Michael, Steens Anneke, Gjein Gaute Eriksen, Sunde Magne Wiken, Iversen Petter, Svanevik Marius, Ahmad Babar Mushtaq, Waldow Thomas, Norheim Arne Johan

机构信息

Norwegian Armed Forces Joint Medical Services Sessvollmoen Norway.

Department of Community Medicine University of Tromsø-The Arctic University of Norway Tromsø Norway.

出版信息

Health Sci Rep. 2021 Jan 15;4(1):e233. doi: 10.1002/hsr2.233. eCollection 2021 Mar.

DOI:10.1002/hsr2.233
PMID:33490637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7810033/
Abstract

BACKGROUND

Accurate estimates of SARS-CoV-2 infection in different population groups are important for the health authorities. In Norway, public infection control measures have successfully curbed the pandemic. However, military training and service are incompatible with these measures; therefore extended infection control measures were implemented in the Norwegian Armed Forces. We aimed to describe these measures, discuss their value, and investigate the polymerase chain reaction (PCR) prevalence and seroprevalence of SARS-CoV-2, as well as changes in antibody titer levels over the 6-week military training period in a young, asymptomatic population of conscripts.

METHODS

In April 2020, 1170 healthy conscripts (median age 20 years) enrolled in military training. Extended infection control measures included a pre-enrollment telephone interview, self-imposed quarantine, questionnaires, and serial SARS-CoV-2 testing. At enrollment, questionnaires were used to collect information on symptoms, and SARS-CoV-2 rapid antibody testing was conducted. Serial SARS-CoV-2 PCR and serology testing were used to estimate the prevalence of confirmed SARS-CoV-2 and monitor titer levels at enrollment, and 3 and 6 weeks thereafter.

RESULTS

At enrollment, only 0.2% of conscripts were SARS-CoV-2 PCR-positive, and seroprevalence was 0.6%. Serological titer levels increased nearly 5-fold over the 6-week observation period. Eighteen conscripts reported mild respiratory symptoms during the 2 weeks prior to enrollment (all were PCR-negative; one was serology-positive), whereas 17 conscripts reported respiratory symptoms and nine had fever at enrollment (all were PCR- and serology-negative).

CONCLUSIONS

The prevalence of SARS-CoV-2 was less than 1% in our sample of healthy Norwegian conscripts. Testing of asymptomatic conscripts seems of no value in times of low COVID-19 prevalence. SARS-CoV-2 antibody titer levels increased substantially over time in conscripts with mild symptoms.

摘要

背景

准确估计不同人群中的新型冠状病毒2(SARS-CoV-2)感染情况对卫生当局而言至关重要。在挪威,公共感染控制措施已成功遏制了疫情大流行。然而,军事训练和服役与这些措施不兼容;因此,挪威武装部队实施了强化感染控制措施。我们旨在描述这些措施,讨论其价值,并调查年轻无症状应征入伍人群在为期6周的军事训练期间SARS-CoV-2的聚合酶链反应(PCR)患病率和血清阳性率,以及抗体滴度水平的变化。

方法

2020年4月,1170名健康应征入伍者(中位年龄20岁)参加军事训练。强化感染控制措施包括入伍前电话访谈、自我隔离、问卷调查和系列SARS-CoV-2检测。入伍时,通过问卷调查收集症状信息,并进行SARS-CoV-2快速抗体检测。采用系列SARS-CoV-2 PCR和血清学检测来估计确诊的SARS-CoV-2患病率,并在入伍时、此后3周和6周监测滴度水平。

结果

入伍时,只有0.2%的应征入伍者SARS-CoV-2 PCR检测呈阳性,血清阳性率为0.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd9/7810033/55b97d95548d/HSR2-4-e233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd9/7810033/93d6c1aeb901/HSR2-4-e233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd9/7810033/55b97d95548d/HSR2-4-e233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd9/7810033/93d6c1aeb901/HSR2-4-e233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd9/7810033/55b97d95548d/HSR2-4-e233-g002.jpg

相似文献

1
Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscripts.1170名无症状挪威应征入伍者中严重急性呼吸综合征冠状病毒2的流行情况
Health Sci Rep. 2021 Jan 15;4(1):e233. doi: 10.1002/hsr2.233. eCollection 2021 Mar.
2
Pre-screening and preventive quarantine likely explains the low SARS-CoV-2 prevalence among Norwegian conscripts.新兵中 SARS-CoV-2 感染率较低可能与预筛查和预防检疫有关。
Scand J Prim Health Care. 2021 Mar;39(1):31-34. doi: 10.1080/02813432.2021.1880101. Epub 2021 Feb 5.
3
Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.意大利中部一所教学医院的卫生工作者(HWs)中 SARS-CoV-2 感染的流行率和诊断检测性能。
Int J Environ Res Public Health. 2020 Jun 19;17(12):4417. doi: 10.3390/ijerph17124417.
4
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
5
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.在 2019 年冠状病毒病疫情后,对一个经过全面 PCR 检测的社区使用六种不同血清学检测方法进行抗体反应的研究——CoNAN 研究。
Clin Microbiol Infect. 2021 Mar;27(3):470.e1-470.e9. doi: 10.1016/j.cmi.2020.11.009. Epub 2020 Nov 20.
6
Case series of coronavirus (SARS-CoV-2) in a military recruit school: clinical, sanitary and logistical implications.军队新兵学校中冠状病毒(SARS-CoV-2)的病例系列:临床、卫生和后勤影响。
BMJ Mil Health. 2021 Aug;167(4):251-254. doi: 10.1136/bmjmilitary-2020-001482. Epub 2020 Apr 16.
7
The seroprevalence of SARS-CoV-2 in a rural southwest community.农村西南社区 SARS-CoV-2 的血清阳性率。
J Osteopath Med. 2021 Feb 1;121(2):199-210. doi: 10.1515/jom-2020-0287.
8
Prevalence of COVID-19 IgG Antibodies in a Cohort of Municipal First Responders.一组市政急救人员中新冠病毒免疫球蛋白G抗体的流行情况
Prehosp Disaster Med. 2021 Apr;36(2):131-134. doi: 10.1017/S1049023X2000151X. Epub 2021 Jan 5.
9
Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.在费城的 2 家医院进行的严重急性呼吸综合征冠状病毒 2 通用检测:2 周内的携带者流行率和症状发展。
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100226. doi: 10.1016/j.ajogmf.2020.100226. Epub 2020 Sep 11.
10
Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response.使用家庭样本采集方法进行全国概率调查的方案,以评估 SARS-CoV-2 感染和抗体反应的流行率和发生率。
Ann Epidemiol. 2020 Sep;49:50-60. doi: 10.1016/j.annepidem.2020.07.015. Epub 2020 Aug 11.

引用本文的文献

1
SARS-CoV-2 Transmission in the Military during the Early Phase of the Pandemic-A Systematic Analysis.SARS-CoV-2 在大流行早期的军队中的传播——系统分析。
Int J Environ Res Public Health. 2022 Jun 16;19(12):7418. doi: 10.3390/ijerph19127418.

本文引用的文献

1
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.人类感染 SARS-CoV-2 后三个月内中和抗体反应的纵向观察和下降。
Nat Microbiol. 2020 Dec;5(12):1598-1607. doi: 10.1038/s41564-020-00813-8. Epub 2020 Oct 26.
2
Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020.2020 年韩国冠状病毒病疫情期间的接触者追踪。
Emerg Infect Dis. 2020 Oct;26(10):2465-2468. doi: 10.3201/eid2610.201315. Epub 2020 Jul 16.
3
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
西班牙 2020 年人群血清流行病学研究(ENE-COVID):全国范围内基于人群的血清流行病学研究。
Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6.
4
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.欧洲儿童和青少年中的 COVID-19:一项多国家、多中心队列研究。
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661. doi: 10.1016/S2352-4642(20)30177-2. Epub 2020 Jun 25.
5
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.从诊断样本中预测传染性严重急性呼吸综合征冠状病毒 2。
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666. doi: 10.1093/cid/ciaa638.
6
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.体液免疫反应在感染 SARS-CoV-2 后的动态变化和再次感染的可能性。
J Gen Virol. 2020 Aug;101(8):791-797. doi: 10.1099/jgv.0.001439.
7
Interpreting Diagnostic Tests for SARS-CoV-2.解读新型冠状病毒2019(SARS-CoV-2)诊断检测结果
JAMA. 2020 Jun 9;323(22):2249-2251. doi: 10.1001/jama.2020.8259.
8
COVID-19 ‒ a mild disease in children.新冠病毒病——一种在儿童中为轻症的疾病。
Tidsskr Nor Laegeforen. 2020 Mar 24;140(6). doi: 10.4045/tidsskr.20.0231. Print 2020 Apr 21.
9
Profile of specific antibodies to SARS-CoV-2: The first report.新型冠状病毒2019(SARS-CoV-2)特异性抗体概况:首次报告
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.012. Epub 2020 Mar 21.
10
Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system.高通量系统评估用于检测新型冠状病毒 SARS-CoV-2 的实时荧光定量 RT-PCR 检测方法。
Euro Surveill. 2020 Mar;25(9). doi: 10.2807/1560-7917.ES.2020.25.9.2000152.